CAD 0.56
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 98.5 Million USD | -5.8% |
2022 | 104.57 Million USD | -12.49% |
2021 | 119.49 Million USD | 69.52% |
2020 | 70.49 Million USD | 10.84% |
2019 | 63.59 Million USD | 200.45% |
2018 | 21.16 Million USD | 135.83% |
2017 | 8.97 Million USD | 494.35% |
2016 | 1.51 Million USD | 0.0% |
2015 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 31.08 Million USD | 35.89% |
2024 Q1 | 22.87 Million USD | -0.4% |
2023 Q4 | 22.96 Million USD | -7.34% |
2023 Q1 | 24.91 Million USD | 0.29% |
2023 Q2 | 25.83 Million USD | 3.68% |
2023 FY | 98.5 Million USD | -5.8% |
2023 Q3 | 24.78 Million USD | -4.04% |
2022 FY | 104.57 Million USD | -12.49% |
2022 Q1 | 25.69 Million USD | -14.01% |
2022 Q3 | 25.62 Million USD | -9.82% |
2022 Q4 | 24.84 Million USD | -3.04% |
2022 Q2 | 28.41 Million USD | 10.58% |
2021 Q1 | 23.81 Million USD | 18.25% |
2021 FY | 119.49 Million USD | 69.52% |
2021 Q2 | 32.84 Million USD | 37.9% |
2021 Q3 | 32.95 Million USD | 0.33% |
2021 Q4 | 29.88 Million USD | -9.32% |
2020 Q4 | 20.13 Million USD | -11.66% |
2020 Q3 | 22.79 Million USD | 111.85% |
2020 Q1 | 16.79 Million USD | 1.53% |
2020 Q2 | 10.76 Million USD | -35.92% |
2020 FY | 70.49 Million USD | 10.84% |
2019 Q4 | 16.54 Million USD | -0.94% |
2019 FY | 63.59 Million USD | 200.45% |
2019 Q3 | 16.69 Million USD | 1.06% |
2019 Q2 | 16.52 Million USD | 19.41% |
2019 Q1 | 13.83 Million USD | 68.21% |
2018 Q2 | 4.42 Million USD | 23.38% |
2018 Q1 | 3.58 Million USD | 6.96% |
2018 Q3 | 4.91 Million USD | 11.03% |
2018 Q4 | 8.22 Million USD | 67.38% |
2018 FY | 21.16 Million USD | 135.83% |
2017 Q2 | 1.46 Million USD | 28.86% |
2017 FY | 8.97 Million USD | 494.35% |
2017 Q1 | 1.13 Million USD | 0.0% |
2017 Q3 | 3.02 Million USD | 106.94% |
2017 Q4 | 3.35 Million USD | 10.88% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | 1.51 Million USD | 0.0% |
2015 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aion Therapeutic Inc. | 367.47 Thousand CAD | -26705.66% |
Ayurcann Holdings Corp. | 25.15 Million CAD | -291.552% |
Blueberries Medical Corp. | 288.27 Thousand CAD | -34070.912% |
The BC Bud Corporation | 61.48 Thousand CAD | -160117.901% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | -26362.314% |
CordovaCann Corp. | 13.59 Million CAD | -624.585% |
Christina Lake Cannabis Corp. | 11.77 Million CAD | -736.229% |
Captor Capital Corp. | 36.76 Million CAD | -167.925% |
City View Green Holdings Inc. | 8582.00 CAD | -1147711.349% |
1CM Inc. | 35.34 Million CAD | -178.724% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | -1783.394% |
IM Cannabis Corp. | 48.8 Million CAD | -101.838% |
Lobe Sciences Ltd. | 840.53 Thousand CAD | -11619.356% |
Maple Leaf Green World Inc. | - CAD | -Infinity% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -164075.283% |
Nextleaf Solutions Ltd. | 8.17 Million CAD | -1104.277% |
Ovation Science Inc. | 61.93 Thousand CAD | -158948.616% |
Pharmadrug Inc. | - CAD | -Infinity% |
Captiva Verde Wellness Corp. | 174.78 Thousand CAD | -56257.263% |
RAMM Pharma Corp. | 5.06 Million CAD | -1844.72% |
RIV Capital Inc. | 7.48 Million CAD | -1215.496% |
Revive Therapeutics Ltd. | - CAD | -Infinity% |
Red White & Bloom Brands Inc. | 88.33 Million CAD | -11.515% |
SLANG Worldwide Inc. | 35.68 Million CAD | -176.062% |
1933 Industries Inc. | 18.27 Million CAD | -439.067% |
Red Light Holland Corp. | 4.75 Million CAD | -1972.929% |
Top Strike Resources Corp. | 13.32 Million CAD | -639.122% |
Xebra Brands Ltd. | 106.85 Thousand CAD | -92085.831% |
Adastra Holdings Ltd. | 22.22 Million CAD | -343.265% |